Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Instagram Outage Disrupts Thousands of U.S. Users 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
 Guidance System - EconoTimes)
ORLANDO, Fla., April 20, 2016 -- On April 4, Dr. Payam Moazzaz performed the 700th Mazor Robotics Renaissance® Spine Surgery case at Tri-City Medical Center. The Renaissance system uses mechanical guidance to help surgeons place pedicle screws and implants with unparalleled accuracy to correct conditions such as scoliosis and degenerative disc disease.
Located in Oceanside, CA, Tri-City Medical Center is a Gold Seal-approved, full-service, acute-care hospital with advanced clinical institutes for orthopaedic and cardiovascular care. Tri-City Medical Center has 397 beds and over 700 physicians practicing in 60 specialties. Tri-City Medical Center purchased its first Renaissance system in February 2012 and a second system in December of the same year.
"The Mazor Robotics system allows us to perform even the most difficult cases with confidence," said Dr. Moazzaz. "With Renaissance, we are able to provide our patients with the best care and that is why we continue to use the technology for so many of our cases."
"Being one of the first hospitals in the country to use Renaissance technology, the surgeons at TCMC are true pioneers in their field," said Mazor Robotics Inc. CEO Christopher Prentice. "We congratulate their team on reaching this milestone and thank everyone at TCMC for truly believing in the technology and helping us to change the landscape of spine surgery."
Since coming to the market in 2011, over 15,000 procedures have been performed with the Renaissance system at over 100 hospitals worldwide. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of spine surgery with Mazor Robotics technology. For more information, please visit www.MazorRobotics.com.
About Mazor
|
|||||
Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing through innovation by developing and introducing revolutionary robotic-based technology and products aimed at redefining the gold standard of quality care. Mazor Robotics Renaissance® Guidance System enables surgeons to conduct spine and brain procedures in a more accurate and secure manner.
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=39907
CONTACT: Stephani Shipman
Marketing Communications Manager
(407) 591-3461
[email protected]
